Wu, T. T.-H. et al. Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung. J. Exp. Med. 221, e20232192 (2024).
Ferreira, A. C. et al. Macrophages undergo necroptosis during severe influenza A infection and contribute to virus-associated cytokine storm. Front. Cell Infect. Microbiol. 16, e1067285 (2023).
Karki, R. et al. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell 184, 149–168.e17 (2021).
DeBerge, M. P., Ely, K. H. & Enelow, R. I. Soluble, but not transmembrane, TNF-α is required during influenza infection to limit the magnitude of immune responses and the extent of immunopathology. J. Immunol. 192, 5839–5851 (2014).
Mestan, J. et al. Antiviral effects of recombinant tumour necrosis factor in vitro. Nature 323, 816–819 (1986).
Wong, G. H. W. & Goeddel, D. V. Tumour necrosis factors α and β inhibit virus replication and synergize with interferons. Nature 323, 819–822 (1986).
Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036–1045.e9 (2020).
Baillie, J. K. & Digard, P. Influenza—time to target the host? N. Engl. J. Med. 369, 191–193 (2013).
Serhan, C. N., Chiang, N. & Van Dyke, T. E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8, 349–361 (2008).
de Jong, M. D. et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12, 1203–1207 (2006).
Moore, J. B. & June, C. H. Cytokine release syndrome in severe COVID-19. Science 368, 473–474 (2020).
Watanabe, T. et al. Influenza virus–host interactome screen as a platform for antiviral drug development. Cell Host Microbe 16, 795–805 (2014).
Weber, G. F. et al. Pleural innate response activator B cells protect against pneumonia via a GM–CSF–IgM axis. J. Exp. Med. 211, 1243–1256 (2014).
Rauch, P. J. et al. Innate response activator B cells protect against microbial sepsis. Science 335, 597–601 (2012).
Yanaba, K. et al. A aegulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28, 639–650 (2008).
Flores-Borja, F. et al. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci. Transl. Med. 5, 173ra23–173ra23 (2013).
Mauri, C. & Bosma, A. Immune regulatory function of B cells. Annu. Rev. Immunol. 30, 221–241 (2012).
Rosser, E. C. & Mauri, C. Regulatory B cells: origin, phenotype, and function. Immunity 42, 607–612 (2015).
Rosser, E. C., Blair, P. A. & Mauri, C. Cellular targets of regulatory B cell-mediated suppression. Mol. Immunol. 62, 296–304 (2014).
Horikawa, M. et al. Regulatory B cell (B10 cell) expansion during Listeria infection governs innate and cellular immune responses in mice. J. Immunol. 190, 1158–1168 (2013).
Suchanek, O. et al. Tissue-resident B cells orchestrate macrophage polarisation and function. Nat. Commun. 14, 7081 (2023).
Li, S. et al. STING-induced regulatory B cells compromise NK function in cancer immunity. Nature 610, 373–380 (2022).
Zhang, B., Vogelzang, A. & Fagarasan, S. Secreted immune metabolites that mediate immune cell communication and function. Trends Immunol. 43, 990–1005 (2022).
Zhang, B. et al. B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity. Nature 599, 471–476 (2021).
Shirey, K. A. et al. Novel neuroendocrine role of γ-aminobutyric acid and gastrin-releasing peptide in the host response to influenza infection. Mucosal Immunol. 16, 302–311 (2023).
Ma, Y., Jun, H. & Wu, J. Immune cell cholinergic signaling in adipose thermoregulation and immunometabolism. Trends Immunol. 43, 718–727 (2022).
Reardon, C. et al. Lymphocyte-derived ACh regulates local innate but not adaptive immunity. Proc. Natl Acad. Sci. USA 110, 1410–1415 (2013).
Nachmansohn, D. & Machado, A. L. The formation of acetylcholine. a new enzyme: ‘choline acetylase’. J. Neurophysiol. 6, 397–403 (1943).
Cai, Y. et al. Choline acetyltransferase structure reveals distribution of mutations that cause motor disorders. EMBO J. 23, 2047–2058 (2004).
Tansey, E. M. Henry Dale and the discovery of acetylcholine. C. R. Biol. 329, 419–425 (2006).
Fishman, M. C. Sir Henry Hallett Dale and acetylcholine story. Yale J. Biol. Med 45, 104–118 (1972).
Loewi, O. Über humorale übertragbarkeit der Herznervenwirkung. Pflügers Arch. 189, 239–242 (1921).
Feldberg, W. & Guimarāis, J. A. The liberation of acetylcholine by potassium. J. Physiol. 86, 306–314 (1936).
Dale, H. H. & Feldberg, W. The chemical transmitter of vagus effects to the stomach. J. Physiol. 81, 320–334 (1934).
Li, T. et al. The vagus nerve and nicotinic receptors involve inhibition of HMGB1 release and aarly pro-inflammatory cytokines function in collagen-induced arthritis. J. Clin. Immunol. 30, 213–220 (2010).
van Maanen, M. A. et al. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum. 60, 114–122 (2009).
Liu, D. et al. The effect of the cholinergic anti-inflammatory pathway on collagen-induced arthritis involves the modulation of dendritic cell differentiation. Arthritis Res. Ther. 20, 263 (2018).
Zheng, W. et al. Acetylcholine ameliorates colitis by promoting IL-10 secretion of monocytic myeloid-derived suppressor cells through the nAChR/ERK pathway. Proc. Natl Acad. Sci. 118, e2017762118 (2021).
Kelly, M. J., Breathnach, C., Tracey, K. J. & Donnelly, S. C. Manipulation of the inflammatory reflex as a therapeutic strategy. C. R. Med 3, 100696 (2022).
Tynan, A., Brines, M. & Chavan, S. S. Control of inflammation using non-invasive neuromodulation: past, present and promise. Int. Immunol. 34, 119–128 (2022).
Pavlov, V. A. & Tracey, K. J. The vagus nerve and the inflammatory reflex—linking immunity and metabolism. Nat. Rev. Endocrinol. 8, 743–754 (2012).
Lei, W. & Duan, Z. Advances in the treatment of cholinergic anti-inflammatory pathways in gastrointestinal diseases by electrical stimulation of vagus nerve. Digestion 102, 128–138 (2019).
Pavlov, V. A., Chavan, S. S. & Tracey, K. J. Molecular and functional neuroscience in immunity. Annu. Rev. Immunol. 36, 783–812 (2018).
Caravaca, A. S. et al. Vagus nerve stimulation promotes resolution of inflammation by a mechanism that involves Alox15 and requires the α7nAChR subunit. Proc. Natl Acad. Sci. USA 119, e2023285119 (2022).
Koopman, F. A. et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 113, 8284–8289 (2016).
Pavlov, V. A. & Tracey, K. J. Bioelectronic medicine: Preclinical insights and clinical advances. Neuron 110, 3627–3644 (2022).
Falvey, A., Metz, C. N., Tracey, K. J. & Pavlov, V. A. Peripheral nerve stimulation and immunity: the expanding opportunities for providing mechanistic insight and therapeutic intervention. Int. Immunol. 34, 107–118 (2022).
Bonaz, B. et al. Chronic vagus nerve stimulation in Crohn’s disease: a 6-month follow-up pilot study. Neurogastroenterol. Motil. 28, 948–953 (2016).
Sinniger, V. et al. A 12-month pilot study outcomes of vagus nerve stimulation in Crohn’s disease. Neurogastroenterol. Motil. 32, e13911 (2020).
Jiang, W. et al. Acetylcholine-producing NK cells attenuate CNS inflammation via modulation of infiltrating monocytes/macrophages. Proc. Natl Acad. Sci. USA 114, E6202–E6211 (2017).
Rosas-Ballina, M. et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334, 98–101 (2011).
Olofsson, P. S. et al. Blood pressure regulation by CD4+ lymphocytes expressing choline acetyltransferase. Nat. Biotechnol. 34, 1066–1071 (2016).
Ramirez, V. T. et al. T-cell derived acetylcholine aids host defenses during enteric bacterial infection with Citrobacter rodentium. PLoS Pathog. 15, e1007719 (2019).
Cox, M. A. et al. Choline acetyltransferase-expressing T cells are required to control chronic viral infection. Science 363, 639–644 (2019).
Chu, C. et al. The ChAT-acetylcholine pathway promotes group 2 innate lymphoid cell responses and anti-helminth immunity. Sci. Immunol. 6, eabe3218 (2021).
Roberts, L. B. et al. Acetylcholine production by group 2 innate lymphoid cells promotes mucosal immunity to helminths. Sci. Immunol. 6, eabd0359 (2021).
Shapira, S. D. et al. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139, 1255–1267 (2009).
Savage, H. P. et al. TLR induces reorganization of the IgM-BCR complex regulating murine B-1 cell responses to infections. eLife 8, e46997 (2019).
Ghoneim, H. E., Thomas, P. G. & McCullers, J. A. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J. Immunol. 191, 1250–1259 (2013).
Liao, M. et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 26, 842–844 (2020).
Malainou, C., Abdin, S. M., Lachmann, N., Matt, U. & Herold, S. Alveolar macrophages in tissue homeostasis, inflammation, and infection: evolving concepts of therapeutic targeting. J. Clin. Invest. 133, e170501 (2023).
Whitsett, J. A. & Weaver, T. E. Hydrophobic surfactant proteins in lung function and disease. N. Engl. J. Med. 347, 2141–2148 (2002).
Veldhuizen, E. J. A. & Haagsman, H. P. Role of pulmonary surfactant components in surface film formation and dynamics. Biochim. Biophys. Acta Biomembranes 1467, 255–270 (2000).
Wei, X., Narasimhan, H., Zhu, B. & Sun, J. Host recovery from respiratory viral infection. Annu. Rev. Immunol. 41, 277–300 (2023).
Narasimhan, H., Wu, Y., Goplen, N. P. & Sun, J. Immune determinants of chronic sequelae after respiratory viral infection. Sci. Immunol. 7, eabm7996 (2022).
Ochsenbein, A. F. et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286, 2156–2159 (1999).
Baumgarth, N. et al. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 192, 271–280 (2000).
Schloss, M. J. et al. B lymphocyte-derived acetylcholine limits steady-state and emergency hematopoiesis. Nat. Immunol. 23, 605–618 (2022).
Becher, B., Waisman, A. & Lu, L.-F. Conditional gene-targeting in mice: problems and solutions. Immunity 48, 835–836 (2018).
Zhao, Y. et al. Altered phenotype and enhanced antibody-producing ability of peripheral B cells in mice with Cd19-driven Cre expression. Cells 11, 700 (2022).
Nguyen, T. T. T. et al. The IgM receptor FcμR limits tonic BCR signaling by regulating expression of the IgM BCR. Nat. Immunol. 18, 321–333 (2017).
Savage, H. P. et al. Blimp-1-dependent and -independent natural antibody production by B-1 and B-1-derived plasma cells. J. Exp. Med. 214, 2777–2794 (2017).
Woznicki, J. A. et al. TNF-α synergises with IFN-γ to induce caspase-8-JAK1/2-STAT1-dependent death of intestinal epithelial cells. Cell Death Dis. 12, 1–15 (2021).
Oyler-Yaniv, J., Oyler-Yaniv, A., Maltz, E. & Wollman, R. TNF controls a speed-accuracy tradeoff in the cell death decision to restrict viral spread. Nat. Commun. 12, 2992 (2021).
Matsumoto, R. et al. Induction of bronchus-associated lymphoid tissue is an early life adaptation for promoting human B cell immunity. Nat. Immunol. 24, 1370–1381 (2023).
Swanson, R. V. et al. Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control. Nat. Immunol. 24, 855–868 (2023).
Czura, C. J., Friedman, S. G. & Tracey, K. J. Neural inhibition of inflammation: the cholinergic anti-inflammatory pathway. J. Endotoxin Res. 9, 409–413 (2003).
Wang, H. et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 421, 384–388 (2003).
Wang, H. et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10, 1216–1221 (2004).
Ulloa, L. The vagus nerve and the nicotinic anti-inflammatory pathway. Nat. Rev. Drug Discov. 4, 673–684 (2005).
Borovikova, L. V. et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458–462 (2000).
Yoshikawa, H. et al. Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-κB phosphorylation and nuclear factor-κB transcriptional activity through nicotinic acetylcholine receptor α7. Clin. Exp. Immunol. 146, 116–123 (2006).
de Jonge, W. J. et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat. Immunol. 6, 844–851 (2005).
Pandey, P. & Karupiah, G. Targeting tumour necrosis factor to ameliorate viral pneumonia. FEBS J. 289, 883–900 (2022).
Peper, R. L. & Van Campen, H. Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. Microb. Pathog. 19, 175–183 (1995).
Salomon, R., Hoffmann, E. & Webster, R. G. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc. Natl Acad. Sci. USA 104, 12479–12481 (2007).
Mettelman, R. C. et al. Baseline innate and T cell populations are correlates of protection against symptomatic influenza virus infection independent of serology. Nat. Immunol. 24, 1511–1526 (2023).
Huang, F.-F. et al. GM-CSF in the Lung Protects against Lethal Influenza Infection. Am. J. Respir. Crit. Care Med. 184, 259–268 (2011).
Sever-Chroneos, Z. et al. GM-CSF modulates pulmonary resistance to influenza A infection. Antiviral Res. 92, 319–328 (2011).
Halstead, E. S. et al. GM-CSF overexpression after influenza a virus infection prevents mortality and moderates M1-like airway monocyte/macrophage polarization. Respir. Res. 19, 3 (2018).
Rabin, R. C. Breakthrough drug for COVID-19 may be risky for mild cases. The New York Times. 24 June 2020; updated, 2 September (2020).
WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA 324, 1330–1341 (2020).
Li, H., Yan, B., Gao, R., Ren, J. & Yang, J. Effectiveness of corticosteroids to treat severe COVID-19: a systematic review and meta-analysis of prospective studies. Int. Immunopharmacol. 100, 108121 (2021).
RECOVERY Collaborative Groupet al. Dexamethasone in Hospitalized Patients with Covid-19. N. Engl. J. Med. 384, 693–704 (2021).
Crothers, K. et al. Dexamethasone in hospitalised COVID-19 patients not on intensive respiratory support. Eur. Respir. J. 60, 2102532 (2022).
Covello, R. D. et al. Meta-analysis of glucocorticoids for Covid-19 patients not receiving oxygen. NEJM Evid. 2, EVIDoa2200283 (2023).
Shang, L., Zhao, J., Hu, Y., Du, R. & Cao, B. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet 395, 683–684 (2020).
Russell, C. D., Millar, J. E. & Baillie, J. K. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 395, 473–475 (2020).
Kopf, M., Schneider, C. & Nobs, S. P. The development and function of lung-resident macrophages and dendritic cells. Nat. Immunol. 16, 36–44 (2015).
Park, M. D., Silvin, A., Ginhoux, F. & Merad, M. Macrophages in health and disease. Cell 185, 4259–4279 (2022).
Aegerter, H., Lambrecht, B. N. & Jakubzick, C. V. Biology of lung macrophages in health and disease. Immunity 55, 1564–1580 (2022).
Morris, D. L. & Rothstein, T. L. Abnormal transcription factor induction through the surface immunoglobulin M receptor of B-1 lymphocytes. J. Exp. Med. 177, 857–861 (1993).
Benschop, R. J., Melamed, D., Nemazee, D. & Cambier, J. C. Distinct signal thresholds for the unique antigen receptor–linked gene expression programs in mature and immature B cells. J. Exp. Med. 190, 749–756 (1999).
Russell, D. M. et al. Peripheral deletion of self-reactive B cells. Nature 354, 308–311 (1991).
Goodnow, C. C. et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334, 676–682 (1988).
Radomir, L. et al. The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5. Nat. Commun. 12, 1893 (2021).
Mauri, C. Novel frontiers in regulatory B cells. Immunol. Rev. 299, 5–9 (2021).
Matsumoto, M. et al. Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity 41, 1040–1051 (2014).
Fillatreau, S. Natural regulatory plasma cells. Curr. Opin. Immunol. 55, 62–66 (2018).
Shen, P. et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507, 366–370 (2014).
Shirey, K. A. et al. Novel role of gastrin releasing peptide-mediated signaling in the host response to influenza infection. Mucosal Immunol. 12, 223–231 (2019).
Tracey, K. J. The inflammatory reflex. Nature 420, 853–859 (2002).
Matthay, M. A. & Ware, L. B. Can nicotine treat sepsis? Nat. Med. 10, 1161–1162 (2004).
Vukelic, M., Qing, X., Redecha, P., Koo, G. & Salmon, J. E. Cholinergic receptors modulate immune complex-induced inflammation in vitro and in vivo. J. Immunol. 191, 1800–1807 (2013).
Nakamura, Y. et al. Alpha 7 nicotinic acetylcholine receptors signaling boosts cell-cell interactions in macrophages effecting anti-inflammatory and organ protection. Commun. Biol. 6, 1–15 (2023).
Doucett, V. P. et al. Enumeration and characterization of virus-specific B cells by multicolor flow cytometry. J. Immunol. Methods 303, 40–52 (2005).
Stuart, T., Srivastava, A., Madad, S., Lareau, C. A. & Satija, R. Single-cell chromatin state analysis with Signac. Nat. Methods 18, 1333–1341 (2021).
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587.e29 (2021).
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRxiv https://doi.org/10.1101/060012 (2021).
Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739–1740 (2011).
Cherry, C. et al. Computational reconstruction of the signalling networks surrounding implanted biomaterials from single-cell transcriptomics. Nat. Biomed. Eng. 5, 1228–1238 (2021).
Andreatta, M. & Carmona, S. J. UCell: robust and scalable single-cell gene signature scoring. Comput. Struct. Biotechnol. J. 19, 3796–3798 (2021).
Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847–2849 (2016).
Gu, Z., Gu, L., Eils, R., Schlesner, M. & Brors, B. Circlize implements and enhances circular visualization in R. Bioinformatics 30, 2811–2812 (2014).
Christensen, A. D., Skov, S., Kvist, P. H. & Haase, C. Depletion of regulatory T cells in a hapten-induced inflammation model results in prolonged and increased inflammation driven by T cells. Clin. Exp. Immunol. 179, 485–499 (2015).
Grinberg-Bleyer, Y. et al. Cutting edge: NF-κB p65 and c-Rel control epidermal development and immune homeostasis in the skin. J. Immunol. 194, 2472–2476 (2015).
Shaabani, N. et al. The probacterial effect of type I interferon signaling requires its own negative regulator USP18. Sci. Immunol. 3, eaau2125 (2018).
Schweiger, B., Zadow, I., Heckler, R., Timm, H. & Pauli, G. Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples. J. Clin. Microbiol. 38, 1552–1558 (2000).
Smith, F. L. et al. B-1 plasma cells require non-cognate CD4 T cell help to generate a unique repertoire of natural IgM. J. Exp. Med. 220, e20220195 (2023).
